Download PDF
Gastroenterologie up2date 2019; 15(02): 121-129
DOI: 10.1055/a-0606-7179
Schritt für Schritt
Georg Thieme Verlag KG Stuttgart · New York

Radiofrequenzablation bei Barrett-Syndrom – Schritt für Schritt

David Albers
,
Brigitte Schumacher
Further Information

Publication History

Publication Date:
24 June 2019 (online)

Also available at
    Permissions and Reprints All articles of this category

Die Behandlung von Barrett-Ösophagus und Barrett-Frühkarzinom ist eine Domäne der endoskopischen organerhaltenden Therapie geworden. Eine Kombination von endoskopischer Resektion und ablativen Verfahren hat hier die besten Ergebnisse gezeigt. Unter den ablativen Verfahren ist die Radiofrequenzablation (RFA) aufgrund guter Ergebnisse und einfacher Handhabung auch bei großen Ablationsarealen als das Standardverfahren anzusehen.

Schlüsselwörter

Barrett-Ösophagus - Barrett-Frühkarzinom - Radiofrequenzablation - Ablationskatheter
 

  • Literatur

  • 1 Dubecz A, Solymosi N, Stadlhuber RJ. et al. Does the incidence of adenocarcinomas of the esophagus and the gastric cardia continue to rise in the twenty-first century? – A SEER database analysis. J Gastrointest Surg 2014; 18: 124-129
    CrossrefPubMedGoogle Scholar
  • 2 Hur C, Miller M, Kong CY. et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer 2013; 119: 1149-1158
    CrossrefPubMedGoogle Scholar
  • 3 Pech O, Behrens A, May A. et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrettʼs esophagus. Gut 2008; 57: 1200-1206
    CrossrefPubMedGoogle Scholar
  • 4 Phoa KN, Pouw RE, Bisschops R. et al. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II). Gut 2016; 65: 555-562
    CrossrefPubMedGoogle Scholar
  • 5 Weusten B, Bisschops R, Coron E. et al. Endoscopic management of Barrettʼs esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2017; 49: 191-198
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Phoa KN, van Vilsteren FG, Weusten B. et al. Radiofrequency ablation vs. endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia. JAMA 2014; 311: 1209-1217
    CrossrefPubMedGoogle Scholar
  • 7 Duits LC, Phoa KN, Curvers WL. et al. Barrettʼs esophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel. Gut 2015; 64: 700-706
    CrossrefPubMedGoogle Scholar
  • 8 Desai TK, Krishnan K, Samala N. et al. The incidence of esophageal adenocarcinoma in non-dysplastic Barrettʼs esophagus: a meta-analysis. Gut 2012; 61: 970-976
    CrossrefPubMedGoogle Scholar
  • 9 Smith CD, Bejarano PA, Melvin WS. et al. Endoscopic ablation of intestinal metaplasia containing high grade dysplasia in esophagectomy patients using a balloon-based ablation system. Surg Endosc 2007; 21: 560-569
    CrossrefPubMedGoogle Scholar
  • 10 Künzli HT, Schölvinck DW, Phoa KN. et al. Simplified protocol for focal radiofrequency ablation using the HALO90 device: short-term efficacy and safety in patients with dysplastic Barrettʼs esophagus. Endoscopy 2015; 47: 592-597
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Pouw RE, Künzli HAT, Bisschops R. et al. Simplified versus standard regimen for focal radiofrequency ablation of dysplastic Barrettʼs oesophagus: a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol 2018; 3: 566-574
    CrossrefPubMedGoogle Scholar
  • 12 Cotton CC, Wolf WA, Pasricha S. et al. Recurrent intestinal metaplasia after radiofrequency ablation for Barrettʼs esophagus: endoscopic findings and anatomic location. Gastrointest Endosc 2015; 81: 1362-1369
    CrossrefPubMedGoogle Scholar
  • 13 Phoa KN, Pouw RE, van Vilsteren FG. et al. Remission of Barrettʼs esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology 2013; 145: 96-104
    CrossrefPubMedGoogle Scholar
  • 14 Gupta M, Iyer PG, Lutzke L. et al. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrettʼs esophagus: results from a US Multicenter Consortium. Gastroenterology 2013; 145: 79-86
    CrossrefPubMedGoogle Scholar
  • 15 Komanduri S, Kahrilas PJ, Krishnan K. et al. Recurrence of Barrettʼs esophagus is rare following endoscopic eradication therapy coupled with effective reflux protocol. Am J Gastroenterol 2017; 112: 556-566
    CrossrefPubMedGoogle Scholar
  • 16 Shaheen NJ, Sharma P, Overholt BF. et al. Radiofrequency ablation in Barrettʼs esophagus with dysplasia. N Engl J Med 2009; 360: 2277-2288
    CrossrefPubMedGoogle Scholar
  • 17 Cotton CC, Haidry R, Thrift AP. et al. Development of evidence-based surveillance intervals after radiofrequency ablation of Barrettʼs esophagus. Gastroenterology 2018; 155: 316-326
    CrossrefPubMedGoogle Scholar
  • 18 Qumseya BJ, Wani S, Desai M. et al. Adverse events after radiofrequency ablation in patients with Barrettʼs esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2016; 14: 1086-1095
    CrossrefPubMedGoogle Scholar